Study for Naltrexone on the Abuse Potential of Methylphenidate

NCT03769064 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

94

Enrollment

INDUSTRY

Sponsor class

Conditions

Naltrexone
Methylphenidate Abuse

Interventions

DRUG: Placebo
DRUG: Methylphenidate 60 mg
DRUG: Treatment Phase Sequence 4213
DRUG: Treatment Phase Sequence 2134
DRUG: Treatment Phase Sequence 1342
DRUG: Treatment Phase Sequence 3421

Sponsor

Avekshan LLC